Loading clinical trials...
Loading clinical trials...
PF-04950615 is a new investigational hypercholesterolemic agent that is being tested in this study to evaluate if it can lower LDL cholesterol.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06451770 · Hypercholesterolemia, Hypertriglyceridemia, and more
NCT04634591 · Obesity, Diabetes Mellitus, and more
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT06568601 · Hypercholesterolemia
NCT06496243 · Dyslipidemias
Achieve Clinical Research, LLC
Birmingham, Alabama
Advance Outcome Management, Inc.
Garden Grove, California
Collaborative Neuroscience Network, Inc
Garden Grove, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions